Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,436 shares at $103.31 ($252K) on 2020-02-07, disclosed to the SEC on 2020-02-11.
Seasonal sale ($252k) by Chief Research Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.31 | 1,218 | $126K | 50.0% |
| 2 | $103.31 | 1,218 | $126K | 50.0% |
| Total | $103.31 avg | 2,436 | $252K | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |